WAM
WST icon

Wakefield Asset Management’s West Pharmaceutical WST Stock Holding History

Wakefield Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7,121
Closed -$2.15M – 216
2022
Q2 		$2.15M Sell
7,121
-93
-1% -$30.3K 0.92% 43
2022
Q1 		$2.96M Sell
7,214
-303
-4% -$119K 1.06% 27
2021
Q4 		$3.53M Sell
7,517
-34
-0.5% -$14.6K 1.22% 14
2021
Q3 		$3.21M Buy
7,551
+83
+1% +$35K 1.21% 16
2021
Q2 		$2.68M Buy
+7,468
New +$2.47M 1.02% 29

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wakefield Asset Management's WST Position: Q3 2022 in Review

Wakefield Asset Management sold out of West Pharmaceutical (WST) in Q3 2022, closing a stake of 7,121 shares — an estimated $2.15M sold.

Wakefield Asset Management first reported a position in WST in Q2 2021 and held it in 5 quarters. The position peaked at $3.53M in Q4 2021. 637 funds tracked by Wall St. Rank hold WST as of Q3 2022.

  • Wakefield Asset Management reported no remaining West Pharmaceutical position as of Q3 2022 after selling out during the quarter.
  • Wakefield Asset Management sold 7,121 West Pharmaceutical shares in Q3 2022, an estimated $2.15M.
  • Wakefield Asset Management first reported a position in West Pharmaceutical in Q2 2021 and held it in 5 quarters.
  • Wakefield Asset Management's West Pharmaceutical position peaked at $3.53M in Q4 2021.
  • 637 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2022.

Based on Wakefield Asset Management's 13F filing for Q3 2022, filed 7 Nov 2022.